Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited
600329
Rangering i aksjer
#4374
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited, along with its... Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited, along with its subsidiaries, primarily manufactures and markets traditional Chinese medicine, Western pharmaceuticals, and various healthcare products within the People's Republic of China. Its business activities are structured into two distinct divisions: Chinese Medicine and Western Medicine. The company's operations extend beyond its core offerings to include the production and distribution of Chinese, Western, and biological pharmaceutical items. It also engages in the wholesale and retail trade of medicines, biochemical pharmaceutical products, and everyday consumer goods, in addition to managing hospitals. Furthermore, Tianjin Pharmaceutical Da Ren Tang provides a comprehensive suite of services such as logistics, inventory management, equipment installation, and drug processing. It also offers pharmaceutical inspection, testing, and advisory services. In terms of its commercial model, the company supplies its proprietary branded medicinal products directly to wholesalers. Conversely, it acquires pharmaceuticals marketed under other brands from distributors, subsequently reselling these to other wholesale clients. Established in 1992 and based in Tianjin, People's Republic of China, the company was previously known as Tianjin Zhong Xin Pharmaceutical Group Corporation Limited before adopting its current name in May 2022.
Aksjekurs
$6.17
Markedsverdi
$3.52B
Endring (1 dag)
-0.05%
Endring (1 år)
-1.86%
Land
CN
Handel Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (600329)
Kategori
Healthcare
Inntekter for Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (600329)
Inntekter i Oct 2026 TTM: 0
Ifølge de nyeste økonomiske rapportene til Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited er selskapets nåværende inntekter (TTM) 0. I 2026 hadde selskapet inntekter på 0 lik inntektene i 2026, som var 0. Inntektene er det totale beløpet et selskap genererer fra salg av varer eller tjenester. I motsetning til fortjeneste trekkes ingen kostnader fra.
Inntektshistorikk for Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited fra 2001 til 2026
Inntekter ved slutten av hvert år
| År | Inntekter | Endre |
|---|---|---|
| 2025 | $702.84M | -29.79% |
| 2024 | $1.00B | -13.82% |
| 2023 | $1.16B | -2.87% |
| 2022 | $1.20B | 10.04% |
| 2021 | $1.09B | 7.51% |
| 2020 | $1.01B | 0.64% |
| 2019 | $1.00B | 8.65% |
| 2018 | $924.41M | 5.71% |
| 2017 | $874.43M | -2.75% |
| 2016 | $899.13M | -17.54% |
| 2015 | $1.09B | -4.70% |
| 2014 | $1.14B | 15.48% |
| 2013 | $990.83M | 20.44% |
| 2012 | $822.65M | 18.08% |
| 2011 | $696.67M | 32.38% |
| 2010 | $526.25M | 24.71% |
| 2009 | $421.97M | 21.73% |
| 2008 | $346.64M | 12.07% |
| 2007 | $309.30M | 11.54% |
| 2006 | $277.30M | -10.61% |
| 2005 | $310.21M | 21.98% |
| 2004 | $254.31M | 1.95% |
| 2003 | $249.43M | 12.25% |
| 2002 | $222.22M | 20.82% |
| 2001 | $183.92M | 0.00% |
Inntekter for lignende selskaper eller konkurrenter
| Selskap | Inntekter | Forskjell i inntekter | Land |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $6.61B | - |
IN
|
